Dr Katharine Aitken MBBS MSc BSc MRCP FRCR MD(Res)
Katharine Aitken was appointed Consultant Clinical Oncologist at the Royal Marsden Hospital in 2015 and Assistant Honorary Faculty at the Institute of Cancer Research in 2017. She specialises in radiotherapy for Upper and Lower GI cancers and Hepatopancreatobiliary (HPB) tumours. Her research interests include the use of stereotactic ablative radiotherapy (SABR) for HPB cancers and oligometastatic disease. She is the Royal Marsden lead for novel developmental work investigating the use of MR guided adaptive radiotherapy for pancreatic and oesophageal cancer.